Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Clinical Pharmacokinetics|April 7, 2018
Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki DiseaseNiels Vande Casteele, Jun Oyamada, Chisato Shimizu, et al.
Journal of the American Heart Association|July 21, 2022
RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki DiseaseChisato Shimizu, Jihoon Kim, Ming He, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Adenovirus, adeno-associated virus and Kawasaki diseaseHiroko Shike, Chisato Shimizu, John T Kanegaye, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|March 21, 2015
Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhoodChisato Shimizu, Alka Sood, Hubert D Lau, et al.
The Journal of Pediatrics|September 25, 2020
Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse TriggersJane C Burns, Laurel L DeHaan, Chisato Shimizu, et al.
Pediatric Research|February 16, 2023
Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical dataJonathan Y Lam, Min-Seob Song, Gi-Beom Kim, et al.
Annual Review of Pathology|October 28, 2025
Pathology of the Coronary Arteries and Myocardium in Kawasaki DiseaseChisato Shimizu, José María Pérez Pomares, Conor J Loy, et al.
European Journal of Immunology|December 16, 2017
Pediatric tolerogenic DCs expressing CD4 and immunoglobulin-like transcript receptor (ILT)-4 secrete IL-10 in response to Fc and adenosineAlessandra Franco, Jeetendra Kumar, Gene Lin, et al.
International Journal of Molecular Sciences|August 12, 2023
Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in ChildrenJihoon Kim, Chisato Shimizu, Ming He, et al.
International Journal of Molecular Sciences|July 9, 2022
T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4- CD8- Double-Negative T CellsLi-En Hsieh, Jaeyoon Song, Alba Grifoni, et al.
Pageof 12